ORBIMED ADVISORS LLC Insider Trading $NXTM NxStage Medical, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is Director in INSULET CORP ($PODD) and 10% Owner in CRYOCOR INC ($CRYO) and Director in CRYOCOR INC ($CRYO) and 10% Owner in Anthera Pharmaceuticals Inc ($ANTH) and Director in Biodel Inc ($BIOD) and Director in NxStage Medical, Inc. ($NXTM) and Director in ATHERSYS, INC / NEW ($ATHX) and 10% Owner in ARYx Therapeutics, Inc. ($ARYX) and Director in ARYx Therapeutics, Inc. ($ARYX).
ORBIMED ADVISORS LLC in NxStage Medical, Inc.
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 13 2010
$NXTM Market Capitalization: $1.80B
$NXTM Previous Close: $27.78
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in NxStage Medical, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALBO, ANTH, ARYX, ATHX, CRYO, PODD, NXTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 22.60 | 2,356 | 53,255 | 0 | 2.4 K to 0 (-100.00 %) |
| Oct 15 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Buy | J | 0.00 | 2,356 | 0 | 2,356 | 0 to 2.4 K |
| Oct 15 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | J | 0.00 | 1,009,524 | 0 | 2,690,476 | 3.7 M to 2.7 M (-27.28 %) |
| Sep 17 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.23 | 54,000 | 876,420 | 3,700,000 | 3.8 M to 3.7 M (-1.44 %) |
| Sep 14 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.49 | 96,000 | 1,583,040 | 3,754,000 | 3.9 M to 3.8 M (-2.49 %) |
| Sep 14 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.70 | 100,000 | 1,670,000 | 3,850,000 | 4 M to 3.9 M (-2.53 %) |
| Sep 14 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.52 | 193,900 | 3,203,228 | 3,950,000 | 4.1 M to 4 M (-4.68 %) |
| Sep 09 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.36 | 8,800 | 143,968 | 4,143,900 | 4.2 M to 4.1 M (-0.21 %) |
| Sep 09 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.50 | 7,000 | 115,500 | 4,152,700 | 4.2 M to 4.2 M (-0.17 %) |
| Sep 09 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.79 | 40,100 | 673,279 | 4,159,700 | 4.2 M to 4.2 M (-0.95 %) |
| Aug 18 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.94 | 100,200 | 1,697,388 | 4,199,800 | 4.3 M to 4.2 M (-2.33 %) |
| Aug 18 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 17.06 | 288,000 | 4,913,280 | 4,300,000 | 4.6 M to 4.3 M (-6.28 %) |
| Aug 18 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 17.11 | 112,000 | 1,916,320 | 4,588,000 | 4.7 M to 4.6 M (-2.38 %) |
| Aug 04 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.31 | 101,100 | 1,648,779 | 4,700,000 | 4.8 M to 4.7 M (-2.11 %) |
| Aug 04 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.41 | 199,200 | 3,269,370 | 4,801,100 | 5 M to 4.8 M (-3.98 %) |
| Aug 04 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.39 | 17,400 | 285,101 | 5,000,300 | 5 M to 5 M (-0.35 %) |
| Jul 29 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.66 | 128,000 | 2,131,942 | 5,017,700 | 5.1 M to 5 M (-2.49 %) |
| Jul 29 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.93 | 572,556 | 9,691,312 | 5,145,700 | 5.7 M to 5.1 M (-10.01 %) |
| Aug 28 2008 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 4.36 | 11,667 | 50,868 | 11,667 | |
| Aug 28 2008 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 5.50 | 1,111,111 | 6,111,111 | 1,111,111 | |
| Aug 28 2008 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Buy | P | 3.50 | 27,700 | 97,052 | 5,718,256 | 5.7 M to 5.7 M (+0.49 %) |
| Aug 25 2008 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 4.36 | 11,667 | 50,868 | 11,667 | |
| Aug 25 2008 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 5.50 | 1,111,111 | 6,111,111 | 1,111,111 | |
| Aug 25 2008 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Buy | P | 3.37 | 108,900 | 367,113 | 5,690,556 | 5.6 M to 5.7 M (+1.95 %) |
| Aug 25 2008 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Buy | P | 3.25 | 26,100 | 84,833 | 5,581,656 | 5.6 M to 5.6 M (+0.47 %) |
Page: 1